Temedica
PrivateLast Round
Series B
Extension
Nov 23, 2022
Total Funding Raised
$44.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Temedica operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series B Extension round in November 2022.
Temedica is a health-tech company that provides a real-world insights ecosystem with a data analytics platform and patient companion apps for the pharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Temedica Comparables
Compare Temedica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XO Life | 85% | |
| mama health technologies GmbH | 80% | |
| CANKADO GmbH | 79% |
For institutional investors. Book with your work email.
Temedica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 23, 2022 | ||||
| Series B | Jan 15, 2020 | ||||
| Seed | Dec 8, 2017 | ||||
| Seed | Oct 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Temedica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Salvia | Series B |
| MIG Capital | Series B, Series B Extension |
| BayStartUP | Seed |
| G+J Digital Ventures | Series B |
| Santo Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 66% MoM.
- Dec 8, 2017
Seed round raised with participation from BayStartUP.
For institutional investors. Book with your work email.
Temedica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Temedica's valuation, stock price, and market status.
Is Temedica a public or private company?
Temedica is a private company.
What is the current stock price of Temedica?
Temedica is a private company, so its shares have no public market price. Caplight tracks Temedica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Temedica worth (valuation)?
Valuation information for Temedica is not publicly available.
Can I buy Temedica stock?
Temedica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Temedica's last funding round?
Temedica's most recent funding round was Series B Extension on November 23, 2022.
Who are the main investors in Temedica?
Key investors in Temedica include Salvia, MIG Capital, Santo Venture Capital.
Will Temedica IPO soon?
No public IPO plans have been announced for Temedica.
How can I track Temedica secondary market activity?
Caplight tracks bids, offers, and trades in Temedica's shares on secondary markets.